Eivor Hernes

1.0k total citations
30 papers, 815 citations indexed

About

Eivor Hernes is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Eivor Hernes has authored 30 papers receiving a total of 815 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Eivor Hernes's work include Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (14 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Eivor Hernes is often cited by papers focused on Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (14 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Eivor Hernes collaborates with scholars based in Norway, Denmark and Finland. Eivor Hernes's co-authors include Sophie D. Fosså, Steinar Tretli, J. M. Nesland, B Otnes, Trude Eid Robsahm, Jens Petter Berg, Sophie D. Fosså, Alv A. Dahl, Åsa Klint and Anssi Auvinen and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, British Journal of Cancer and European Urology.

In The Last Decade

Eivor Hernes

29 papers receiving 787 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eivor Hernes Norway 14 379 320 149 145 138 30 815
Dean Ruether Canada 12 242 0.6× 263 0.8× 106 0.7× 213 1.5× 103 0.7× 39 710
Jamal Zekri Saudi Arabia 14 367 1.0× 653 2.0× 190 1.3× 118 0.8× 174 1.3× 68 945
Phillip Blanchette Canada 16 279 0.7× 615 1.9× 106 0.7× 92 0.6× 125 0.9× 58 1.0k
Giovanni Gerardo Cardellino Italy 17 340 0.9× 416 1.3× 126 0.8× 173 1.2× 77 0.6× 49 768
Yüksel Küçükzeybek Türkiye 20 298 0.8× 728 2.3× 215 1.4× 151 1.0× 73 0.5× 102 1.2k
Megan Kennedy Ireland 14 330 0.9× 571 1.8× 136 0.9× 202 1.4× 54 0.4× 33 976
Hye Sook Han South Korea 19 258 0.7× 352 1.1× 229 1.5× 141 1.0× 64 0.5× 72 789
Azzurra Onofri Italy 15 382 1.0× 376 1.2× 193 1.3× 113 0.8× 55 0.4× 39 838
Anna Ceribelli Italy 15 449 1.2× 577 1.8× 159 1.1× 112 0.8× 52 0.4× 35 1.0k
Emma Link Australia 16 230 0.6× 296 0.9× 256 1.7× 309 2.1× 91 0.7× 54 930

Countries citing papers authored by Eivor Hernes

Since Specialization
Citations

This map shows the geographic impact of Eivor Hernes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eivor Hernes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eivor Hernes more than expected).

Fields of papers citing papers by Eivor Hernes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eivor Hernes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eivor Hernes. The network helps show where Eivor Hernes may publish in the future.

Co-authorship network of co-authors of Eivor Hernes

This figure shows the co-authorship network connecting the top 25 collaborators of Eivor Hernes. A scholar is included among the top collaborators of Eivor Hernes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eivor Hernes. Eivor Hernes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tandstad, Torgrim, Trond Velde Bogsrud, Eivor Hernes, et al.. (2024). Added Value of [18F]PSMA‐1007 PET/CT and PET/MRI in Patients With Biochemically Recurrent Prostate Cancer: Impact on Detection Rates and Clinical Management. Journal of Magnetic Resonance Imaging. 61(1). 466–477. 2 indexed citations
3.
Hernes, Eivor, Roslyn J. Francis, Anna K. Nowak, et al.. (2024). Outcome prediction based on [18F]FDG PET/CT in patients with pleural mesothelioma treated with ipilimumab and nivolumab +/- UV1 telomerase vaccine. European Journal of Nuclear Medicine and Molecular Imaging. 52(2). 693–707. 2 indexed citations
4.
Hernes, Eivor, et al.. (2023). Stability of metabolic tumor volume may enable radiotherapy dose painting in anal cancer. Physica Medica. 114. 103151–103151. 1 indexed citations
5.
Hernes, Eivor, Mona-Elisabeth Revheim, Knut Håkon Hole, et al.. (2021). Prostate-Specific Membrane Antigen PET for Assessment of Primary and Recurrent Prostate Cancer with Histopathology as Reference Standard. PET Clinics. 16(2). 147–165. 6 indexed citations
6.
Seierstad, Therese, Knut Håkon Hole, Hilde Strømme, et al.. (2021). 18F-Fluciclovine PET for Assessment of Prostate Cancer with Histopathology as Reference Standard. PET Clinics. 16(2). 167–176. 4 indexed citations
7.
Hernes, Eivor, et al.. (2019). Metastatic-directed therapy using PSMA-PET/CT at PSA relapse. Urology Case Reports. 27. 100992–100992. 1 indexed citations
8.
Hernes, Eivor, et al.. (2017). Target volume delineation of anal cancer based on magnetic resonance imaging or positron emission tomography. Radiation Oncology. 12(1). 147–147. 18 indexed citations
9.
Kristian, Alexandr, Turid Torheim, Cecilia Marie Futsæther, et al.. (2016). Dynamic 2-Deoxy-2-[18F]Fluoro-D-Glucose Positron Emission Tomography for Chemotherapy Response Monitoring of Breast Cancer Xenografts. Molecular Imaging and Biology. 19(2). 271–279. 5 indexed citations
10.
Fosså, Sophie D., et al.. (2013). Treatment and 5-Year Survival in Patients With Nonmetastatic Prostate Cancer: The Norwegian Experience. Urology. 83(1). 146–153. 21 indexed citations
11.
Dahl, Alv A., et al.. (2010). Fatigue in hormone-naïve prostate cancer patients treated with radical prostatectomy or definitive radiotherapy. Prostate Cancer and Prostatic Diseases. 13(2). 144–150. 21 indexed citations
12.
Dahl, Alv A., et al.. (2010). Fatigue in prostate cancer survivors treated with definitive radiotherapy and LHRH analogs. The Prostate. 70(13). 1480–1489. 26 indexed citations
13.
Tretli, Steinar, et al.. (2009). Association between serum 25(OH)D and death from prostate cancer. British Journal of Cancer. 100(3). 450–454. 127 indexed citations
14.
Hernes, Eivor, et al.. (2009). Initial management of prostate cancer: first year experience with the Norwegian National Prostate Cancer Registry. British Journal of Urology. 105(6). 805–811. 36 indexed citations
15.
Hernes, Eivor, Lars Johansson, Sophie D. Fosså, Anne Pedersen, & Eystein Glattre. (2008). High prostate cancer mortality in Norway evaluated by automated classification of medical entities. European Journal of Cancer Prevention. 17(4). 331–335. 1 indexed citations
16.
Kvåle, Reidar, Anssi Auvinen, H-O Adami, et al.. (2007). Interpreting Trends in Prostate Cancer Incidence and Mortality in the Five Nordic Countries. JNCI Journal of the National Cancer Institute. 99(24). 1881–1887. 152 indexed citations
17.
Hernes, Eivor, Sverre Harvei, Eystein Glattre, Finn Gjertsen, & Sophie D. Fosså. (2005). High prostate cancer mortality in Norway: Influence of Cancer Registry information?. Apmis. 113(7-8). 542–549. 12 indexed citations
18.
Hernes, Eivor, et al.. (2004). Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence. British Journal of Cancer. 90(2). 449–454. 135 indexed citations
19.
Fosså, Alexander, Aasmund Berner, Sophie D. Fosså, et al.. (2004). NY‐ESO‐1 protein expression and humoral immune responses in prostate cancer. The Prostate. 59(4). 440–447. 63 indexed citations
20.
Hernes, Eivor, Sophie D. Fosså, & Eva Skovlund. (2003). Androgen-independent Prostate Cancer The Clinical Problem of a Growing Pelvic Tumour. Acta Oncologica. 42(7). 749–755. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dean Ruether Breakdown of academic impact, for papers by Jamal Zekri Breakdown of academic impact, for papers by Phillip Blanchette Breakdown of academic impact, for papers by Giovanni Gerardo Cardellino Breakdown of academic impact, for papers by Yüksel Küçükzeybek Breakdown of academic impact, for papers by Megan Kennedy Breakdown of academic impact, for papers by Hye Sook Han Breakdown of academic impact, for papers by Azzurra Onofri Breakdown of academic impact, for papers by Anna Ceribelli Breakdown of academic impact, for papers by Emma Link
Rankless by CCL
2026